AEMD

Aethlon Medical Inc. Common Stock (AEMD)

Stock · NASDAQ · Health Care

$5.15as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 3, 2026

AEMD Holds Shareholder/Analyst Call, Transcript Released. Aethlon Medical Inc. released a transcript of its recent shareholder and analyst call. The prepared remarks provided management’s update on company developments and outlook. The release gives investors additional information to assess the business amid the stock’s elevated RSI reading.

Active signals

Support level
$2.21
Industry
Medical/Dental Instruments

What AEMD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakout20-18.1%20%
Bollinger Band Breakdown20-15.8%30%
Volume Spike17-4.9%35%
200-Day Moving Average TouchActive now3-22.7%33%
Any 20-session window (baseline)-11.1%33%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About AEMD

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
9

Fundamentals

1-day range
$5.07$5.3
Market cap
$1.96M
P/E (trailing)
—
P/E (forward)
-8.96
EPS (trailing)
$-42.46
Dividend yield
—
Beta
1.21
Avg. volume
2.56M
Dividend pay date
October 15, 2019
52-week range
$1.41$35.95
Next earnings: August 13, 2026 · EPS estimate $-4.05confirmed

How Aethlon Medical Inc. Common Stock Makes Money

Where the revenue actually goes — FY2018 annual results

market-wall.comTotalRevenue$149.6KSG&A$792.6K (530%)AEMD

Source: 10-K filed Jun 8, 2018 · via SEC EDGAR / Finnhub

Operating Income-$4.83M(-3229%)

Forecasts

2 analyst ratings

Buy 0%
Hold 57%
Sell 43%
1-year price forecast
High
$25
+385.4%
Median
$13.25
+157.3%
Low
$1.5
-70.9%

Aethlon Medical Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • AEMD
    Aethlon Medical Inc. Common Stock
    $5.15
    ▼ 2.28%
    Market cap $1.96MP/E —
    $1.41$35.95
  • TNON
    Tenon Medical Inc. Common Stock
    $2.7
    ▼ 7.22%
    Market cap $1.99MP/E —
    $2.4$50.4
  • IVF
    INVO Fertility Inc. Common Stock
    $0.558
    ▼ 5.58%
    Market cap $2.39MP/E —
    $0.58$84.4
  • BEATW
    Heartbeam Inc. Warrant
    $0.0031
    ▼ 65.56%
    Market cap $1.19MP/E —
    $0.005$0.5601
  • BJDX
    Bluejay Diagnostics Inc. Common Stock
    $0.745
    ▼ 4.36%
    Market cap $1.19MP/E —
    $0.755$16.68
  • VTAK
    Catheter Precision Inc. Common Stock
    $0.84
    ▼ 14.29%
    Market cap $977.1KP/E —
    $0.82$30.6
  • NXGL
    NexGel Inc Common Stock
    $5.59
    ▲ 7.92%
    Market cap $3.13MP/E —
    $3$57

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
87.3K
Disposed
5.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.